We are live on ! Find out more
CIA

CSat Investment Advisory Portfolio holdings

AUM $119M
1-Year Est. Return 77.51%
This Fund
S&P 500
This Quarter Est. Return
+0.91%
1 Year Est. Return
+77.51%
3 Year Est. Return
+87.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$318M
AUM Growth
+$35M
Cap. Flow
+$33.3M
Cap. Flow %
10.46%
Top 10 Hldgs %
39.42%
Holding
1,085
New
8
Increased
893
Reduced
156
Closed
17

Top Buys

Rank Stock Value
1
NTES icon
NetEase
NTES
+$1.34M
2
AMTD
TD Ameritrade Holding Corp
AMTD
+$1.31M
3
HPQ icon
HP
HPQ
+$1.17M
4
ICE icon
Intercontinental Exchange
ICE
+$973K
5
META icon
Meta Platforms (Facebook)
META
+$641K

Top Sells

Rank Stock Value
1
BBBY
Bed Bath & Beyond
BBBY
+$2.93M
2
INTC icon
Intel
INTC
+$1.32M
3
XNET
Xunlei
XNET
+$1.05M
4
HSY icon
Hershey
HSY
+$684K
5
JD icon
JD.com
JD
+$632K

Sector Composition

Rank Sector Weight
1 Technology 14.95%
2 Financials 13.94%
3 Consumer Discretionary 10.46%
4 Communication Services 10.06%
5 Industrials 5.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LYFT icon
226
Lyft
LYFT
$6.63B
$172K 0.05%
4,207
+1,423
+51% +$77.7K
SYNH
227
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$172K 0.05%
3,238
+568
+21% +$29.1K
HAPN
228
Happen Inc
HAPN
$2.24B
$171K 0.05%
13,036
+3,258
+33% +$47.1K
SYK icon
229
Stryker
SYK
$130B
$171K 0.05%
788
+75
+11% +$16.1K
BIO icon
230
Bio-Rad Laboratories Class A
BIO
$9.42B
$170K 0.05%
511
+89
+21% +$29K
PXD
231
DELISTED
Pioneer Natural Resource Co.
PXD
$170K 0.05%
1,351
+215
+19% +$28.4K
EXAS
232
DELISTED
Exact Sciences
EXAS
$169K 0.05%
1,866
+325
+21% +$37K
INTU icon
233
Intuit
INTU
$89B
$169K 0.05%
634
+77
+14% +$21.2K
PRLB icon
234
Protolabs
PRLB
$2.13B
$169K 0.05%
1,657
+1,115
+206% +$114K
SBRA icon
235
Sabra Healthcare REIT
SBRA
$5.37B
$168K 0.05%
7,319
+1,437
+24% +$30.7K
VICI icon
236
VICI Properties
VICI
$29.4B
$168K 0.05%
7,438
+1,396
+23% +$30.5K
CHTR icon
237
Charter Communications
CHTR
$18.2B
$166K 0.05%
404
+52
+15% +$21K
SSNC icon
238
SS&C Technologies
SSNC
$18.6B
$165K 0.05%
3,207
+506
+19% +$25.9K
NBIX icon
239
Neurocrine Biosciences
NBIX
$16.6B
$164K 0.05%
1,824
+328
+22% +$30.6K
BDX icon
240
Becton Dickinson
BDX
$48.2B
$161K 0.05%
654
+76
+13% +$18.8K
LOW icon
241
Lowe's Companies
LOW
$125B
$160K 0.05%
1,461
+147
+11% +$15.5K
OXY icon
242
Occidental Petroleum
OXY
$55.9B
$160K 0.05%
3,601
+777
+28% +$36.7K
ISRG icon
243
Intuitive Surgical
ISRG
$134B
$159K 0.05%
885
+102
+13% +$17.6K
JOYY
244
JOYY Inc
JOYY
$3.75B
$158K 0.05%
2,812
+916
+48% +$55.6K
PSX icon
245
Phillips 66
PSX
$81.4B
$157K 0.05%
1,537
+129
+9% +$12.9K
EB
246
DELISTED
Eventbrite
EB
$156K 0.05%
8,805
-681
-7% -$11.9K
DE icon
247
Deere & Co
DE
$168B
$155K 0.05%
922
+124
+16% +$19.8K
EXEL icon
248
Exelixis
EXEL
$13.4B
$154K 0.05%
8,701
+1,526
+21% +$30.9K
LBRDK icon
249
Liberty Broadband Class C
LBRDK
$5.15B
$151K 0.05%
1,443
+249
+21% +$26K
SSYS icon
250
Stratasys
SSYS
$774M
$151K 0.05%
7,104
+2,459
+53% +$62.1K
8 9
10
11 12

Similar funds

FLSMF
Fundsmith Long/Short Master Fund Grand Cayman, Cayman Islands $121M AUM
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
IC
Investment Counsel Petoskey, Michigan $142M AUM 36.99% 1-Year Est. Return
BP
Banbury Partners Charlotte, North Carolina $161M AUM 78.27% 1-Year Est. Return
NI
Northwood Investors Denver, Colorado $73.8M AUM
EFM
Ennismore Fund Management London, United Kingdom $71.7M AUM 92.16% 1-Year Est. Return
WU
Wealthsimple US Brooklyn, New York $169M AUM 27.29% 1-Year Est. Return
EH
Employers Holdings Reno, Nevada $170M AUM 58.66% 1-Year Est. Return

CSat Investment Advisory's Q3 2019 Portfolio in Review

As of Q3 2019, CSat Investment Advisory held 1,085 positions worth $318M, up 12% from $283M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

CSat Investment Advisory deployed $33.3M of net new capital in Q3 2019, opening 8 new positions and adding to 893 existing holdings. Its largest new stake was Arena Pharmaceuticals Inc: 10,224 shares worth $468K.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Bed Bath & Beyond, an estimated $2.93M trimmed.

  • CSat Investment Advisory's largest Q3 2019 buy was Arena Pharmaceuticals Inc: 10,224 shares worth $468K.
  • CSat Investment Advisory added most to NetEase in Q3 2019, an estimated $1.34M increase.
  • CSat Investment Advisory's biggest Q3 2019 reduction was Bed Bath & Beyond, cutting an estimated $2.93M.
  • CSat Investment Advisory fully exited Xunlei in Q3 2019, selling an estimated $1.05M.
  • CSat Investment Advisory's ten largest holdings make up 39% of its $318M portfolio in Q3 2019.
  • CSat Investment Advisory opened 8 new positions and closed 17 in Q3 2019.
  • CSat Investment Advisory's portfolio value rose 12% quarter-over-quarter to $318M.

Based on CSat Investment Advisory's 13F filing for Q3 2019, filed 14 Nov 2019.